The human body is complex, and many things can go wrong while a baby is developing. Sometimes, genetic mutations occur, or things don’t form quite right. One condition that can result from ...

A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...

An optic nerve glioma is a type of noncancerous, slow-growing tumor that develops in the glial cells of the optic nerve. They are most common in children. Doctors may refer to this type of tumor as ...

When your optic nerve doesn’t develop all the way, you may not be able to see through that area of your eye. This congenital condition is most often experienced by people who have mothers with ...

Optic atrophy is a condition in which the optic nerve begins to deteriorate. The optic nerve is the nerve at the back of your eye that connects your eye to your brain, allowing you to see. There are a ...

Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced a greater risk of a stroke of the optic nerve, which can lead to blindness, according to a new study ...

Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — In this video, Christine Curcio, PhD, FARVO, discusses how her research into the role of drusen ...

The use of GLP-1 receptor agonists, and particularly liraglutide, was associated with an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) during the first year of ...

PHOENIX — Historically, optic nerve involvement has been excluded from multiple sclerosis (MS) diagnostic criteria, but its inclusion in the upcoming 2024 McDonald Diagnostic Criteria is expected to ...

The risk of new-onset diabetic retinopathy (DR) increased slightly, but significantly, in patients taking GLP-1 receptor agonists for diabetes, despite a lower risk of vision-threatening complications ...